Skip to main content

Table 2 Post-hoc t-test results looking at [11C]DTBZ BPND differences between PD-RBD− vs. healthy controls and PD-RBD+ vs. healthy controls

From: VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder

Basal ganglia ROIs

(A) PD-RBD− vs healthy controls

(B) PD-RBD+ vs healthy controls

t value

p value

t value

p value

Caudate

4.38

 < 0.001

3.72

0.002

Putamen

8.44

 < 0.001

7.76

0.001

Subthalamus

3.02

0.013

1.96

0.168

Ventral striatum

3.77

0.002

2.84

0.021

Associative striatum

5.59

 < 0.001

4.84

 < 0.001

Motor striatum

9.51

 < 0.001

8.89

 < 0.001

External globus pallidus

6.92

 < 0.001

6.68

 < 0.001

Internal globus pallidus

3.33

0.006

3.49

0.04

Substantia nigra

3.90

0.001

2.35

0.072

  1. This table displays the Bonferroni corrected post-hoc t-test results for significant ROIs detected through the mixed effects model. Column A on the left displays results looking at [11C]DTBZ BPND differences between PD patients without probable RBD (PD-RBD−) and healthy controls. Column B on the right shows results between PD patients with probable RBD (PD-RBD+) and healthy controls